Granuloma Annulare

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-03-04
Clinical Trial Update: Janus Kinase Inhibition in Granuloma Annulare [Phase 2]
A Phase 2 clinical trial evaluating a Janus kinase inhibitor for granuloma annulare is currently active but not recruiting.